Biologic properties of breast cancer in men that might reflect alterations in pathogenesis
from the disease in women were examined. We studied 22 tumors from males, 18 invasive …

Male breast carcinomas are probably hormone‐dependent, but receptor studies are few
because this is a relatively rare tumour, We have studied 21 cases of male breast carcinoma …

Steroid receptor analysis is the only widely accepted prognostic/predictive marker in breast
cancer (BC) treatment. In the present study we evaluated the prognostic role of ER/PgR with …

This study was designed to evaluate the prognostic importance of c-erbB-2 and proliferating
cell nuclear antigen (PCNA) with long-term follow-up in Japanese patients with breast …

BACKGROUND Although p53 and HER‐2/neu overexpression are found in 30% of breast
carcinomas in women of all ages and are associated with high rates of lymph node …

Simultaneous overexpression of c-erbB-2 and p53 has been reported to be prognostically
unfavorable in breast cancer. Herein, we show that concurrent overexpression of these 2 …

It is well-known that male breast cancer (MBC) susceptibility is mainly due to high-
penetrance BRCA1/2 mutations. Here, we investigated whether common low-penetrance …

A series of 193 archival breast cancer biopsies were analysed immunohistochemically to
detect over-expression of c-erbB-2 oncoprotein. Altogether, 59/193 (31%) of the tumours …

BACKGROUND: The expressions of p53 protein and c-erbB2 have been thoroughly
analyzed as prognostic factors for breast cancer. However, the prognostic significance of the …

Background: We studied the associations between c-erbB-2 protein overexpression and p53
protein accumulation in benign breast tissue and the risk of subsequent breast cancer …